UNTREATED ADVANCED NSCLC

Clinical trials for UNTREATED ADVANCED NSCLC explained in plain language.

Never miss a new study

Get alerted when new UNTREATED ADVANCED NSCLC trials appear

Sign up with your email to follow new studies for UNTREATED ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial offers hope for Tough-to-Treat lung cancer

Disease control Recruiting now

This study is testing a new drug called STK-012 for people with advanced non-small cell lung cancer and other solid tumors. Researchers want to see if STK-012 works better when given alone or combined with standard cancer treatments. The trial will involve about 364 participants …

Matched conditions: UNTREATED ADVANCED NSCLC

Phase: PHASE1, PHASE2 • Sponsor: Synthekine • Aim: Disease control

Last updated Apr 01, 2026 20:11 UTC

UNTREATED ADVANCED NSCLC

Get alerted when new UNTREATED ADVANCED NSCLC trials appear

New drug trial offers hope for Tough-to-Treat lung cancer